340 likes | 478 Views
PATHOLOGY: RT 91 INTRODUCTION. CHAPTER 1 Spring 2008. HEALTH IN THE UNITED STATES. Chronic diseases continues to be the leading causes of death in the U.S. Diseases of the heart and malignant neoplasm were the top two causes of deaths in 2000. Responsible for over 50% of all deaths.
E N D
PATHOLOGY: RT 91 INTRODUCTION CHAPTER 1 Spring 2008
HEALTH IN THE UNITED STATES • Chronic diseases continues to be the leading causes of death in the U.S. • Diseases of the heart and malignant neoplasm were the top two causes of deaths in 2000. • Responsible for over 50% of all deaths.
As of 2004 it continues to be… • Heart disease: 654,092 • Cancer: 550,270 • Stroke (cerebrovascular diseases): 150,147 • Chronic lower respiratory diseases:123,884 • Accidents (unintentional injuries): 108,694 • Diabetes: 72,815 • Alzheimer's disease: 65,829 • Influenza/Pneumonia: 61,472 • Nephritis, nephrotic syndrome, and nephrosis: 42,762 • Septicemia: 33,464 • Source: Deaths: Preliminary Data for 2004
HEALTH CARE RESOURCES • HEALTH CARE: 13% OF THE GROSS NATIONAL DOMESTIC PRODUCT • US SPENDS MORE MONEY ON HEALTH CARE THAN AN OTHER INDUSTRALIZED NATION • 17% OF U.S. POPULATION: NO HEALTH INSURANCE.
US Dept. of Health and Human Services www.cms.hhs.gov • 16.0 percent of GNP in 2004 • The U.S. spent $1.9 trillion on health care, or $6,280 per person, in 2004. Health spending rose 7.9 percent in 2004, slower than the 8.2 percent growth in 2003 and 9.1 percent growth in 2002. • Of this increases 20% was spent on new technology
TRENDS IN HEALTH CARE • PREVENTION • MUCH CHEAPER TO PREVENT DISEASES THAN TREAT DISEASES • HOW IS THIS AFFFECTING RADIOLOGY?
STRUCTURAL VS FUNCTIONAL DISEASE • STRUCTURAL – HEREDITARY DISORDERS, INFLAMMATORY DISEASES, ETC • FUNCTIONAL – NO LESION PRESENT EX: MENTAL ILLNESS, TENSION HEADACHES, IBS
CONGENITAL & HEREDITARY INFLAMMATORY DEGENERATIVE METABOLIC TRAUMATIC NEOPLASTIC DISEASE CLASSIFICATION
CONGENITAL & HEREDITARY DISEASE • DISEASES THAT ARE PRESENT AT BIRTH AND RESULT FROM GENETIC OR ENVIRONMENTAL FACTORS. • 2% TO 3% OF ALL LIVE BIRTHS SHOW CONGENITAL ABNORMALITIES. • TYPES OF CONGENITAL ABNORMALITIES? HEREDITARY
INFLAMMATORY DISEASE • DISEASE THAT RESULTS FROM THE BODY’S RXN TO LOCALIZED INJURIOUS AGENT • EXAMPLES ? • AUTOIMMUNE DISORDERS
INFLAMMATION • THE BODY’S RESPONSE TO INJURY LOCALIZE/ISOLATE TOXIC SUBSTANCES – DESTROYS “ENEMY” BEGINS WOUND HEALTING AND REPAIR • ACUTE INFLAMMATION – 5 SIGNS
ACUTE INFLAMMATION • RED SKIN – CONGESTION OF BLOOD VESSELS • SWELLING (EDEMA) • HEAT – TEMPERATURE OF THE SKIN • PAIN • LOSS OF FUNCTION • CELLULAR NECROSIS IS COMMON
CHRONIC INFLAMMATION • LASTS FOR LONG PERIODS OF TIME OR LIFETIME • NECROSIS NOT COMMON • EX: EMPHYSEMA, DENTAL CARIES
Transudates Watery serum passing through a membrane Exudates Thick cloudy, protein rich fluid INFLAMMATION FLUIDS
Inflammatory Lesions • Abscess • Cellulitis • Ulcers
REPAIR • Regeneration • Fibrous Connective Tissue
DEGENERATIVE DISEASE • DISEASES ARE CAUSED BY A DETERIORATION OF THE BODY • EX: OSTEOPOROSIS, OSTEOARTHRITIS, ATHEROSCLEROSIS
METABOLIC DISEASE • DISEASES CAUSED BY A DISTURBANCE OF THE NORMAL PHYSIOLOGICAL FUNCTION OF THE BODY. ENDOCRINE DISORDERS • EX: DIABETES
TRAUMATIC DISEASE • DISEASES FROM MECHANICAL FORCES • EX: FRACTURES, BRUISES
NEOPLASTIC DISEASE • ABNORMAL TISSUE GROWTH • BENIGN • MALIGNANT • CARCINOMA • SARCOMA • LEUKEMIAS • LYMPHOMAS
GROWTH DISTURBANCES • INCREASED RATE OF THE GROWTH OF CELLS (PROLIFERATION) • 2 TYPES : Hyperplasia & Hypertrophy • HYPERPLASIA – INCREASE IN THE NUMBER OF CELLS IN TISSUE – EXAGGERATED RESPONSE TO STIMULI – STOPS AFTER STIMULI IS REMOVED. EXAMPLE ? – PYLORIC STENOSIS
CELL GROWTH TERMS • HYPERTROPHY – INCREASED CELL SIZE • METAPLASIA – NORMAL TO ABNORMAL CELL CHANGES • DYSPLASIA – ABNORMAL DEVELOPMENT OF TISSUE
NEOPLASMS • NEW, ABNORMAL TISSUE GROWTH. • LESION: DESCRIBES THE MANY TYPES OF CELLULAR CHANGES IN RESPONSE TO DISEASE • ABNORMAL CELL GROWTH LEADS TO EITHER A BENIGN OR MALIGNANT TUMOR OR NEOPLASM
TUMORS – BENIGN/MALIGNANT • BENIGN – NONCANCEROUS, LEAST SERIOUS, BUT CAN BE FATAL ? • MALIGNANT – CANCEROUS, GROWITH UNCONROLLED
BENIGN NEOPLAMS • REMAIN LOCALIZED • GENERALLY NONINVASIVE
MALIGNANT NEOPLASM • CONTINUES TO GROW, SPREAD AND INVADE OTHER TISSUES • DIFFERENTIATED • BENIGN • UNDIFFERENTIATED • HIGHLY SUSPISIOUS
METASTATIC SPREAD • HEMATOGENOUS SPREAD • LYMPHATIC SPREAD • INVASION • SEEDING
CANCERS • CARCINOMA-EPITHELIAL TISSUE • SARCOMA-CONNECTIVE TISSUE • LEUKEMIA-BLOOD • LYMPHOMA-LYMPHATIC SYSTEM
BENIGN VS MALIGNANT • BENIGN = WORD ROOT IS ADDED TO “OMA” – LIPOMA • MALIGNANT = WORD ROOT IS ADDED TO “CARCINOMA” - ADENOCARCINOMA
STAGING OF CANCER • STAGING HELPS DETERMINE THE APPROPRIATE TREATMENT OF MALIGNANT TUMORS AND DETERMINING PROGNOSIS. • TNM SYSTEM
TNM • T = THE SIZE OF THE UNTREATED PRIMARY CANCER OR TUMOR • N = LYNPH NODE INVOLVEMENT • M = EXTENT OF DISTANT METASTASIS
Epidemiology • Measured over a period of time usually 1 year • Frequency • Incidence • Prevalence
QUESTIONS? • HOMEWORK ASSIGNMENT • Pathology Terms
DISEASE PATHOGENESIS SYMPTOM SIGNS SYNDROME ASYMPTOMATIC ETIOLOGY NOSOCOMIAL IATROGENIC ISCHEMIA IDIOPATHIC ACUTE CHRONIC DIAGNOSIS PROGNOSIS EPIDEMIOLOGY MORTALITY RATE MORBIDITY RATE INFARCT NECROSIS THROMBI/EMBOLI PATHOLOGIC TERM ACTIVITYFOR NEXT CLASS MEETING